Early events play a decisive role in virus multiplication. We have shown previously that activation of MAPK/ERK1/2 (mitogen-activated protein kinase/extracellular-signal-regulated kinase 1/2) and protein kinase A are pivotal for vaccinia virus (VV) multiplication [de Magalhães, Andrade, Silva, Sousa, Ropert, Ferreira, Kroon, Gazzinelli and Bonjardim (2001) J. Biol. Chem. 276, 38353–38360]. In the present study, we show that VV infection provoked a sustained activation of both ERK1/2 and RSK2 (ribosomal S6 kinase 2). Our results also provide evidence that this pattern of kinase activation depends on virus multiplication and ongoing protein synthesis and is maintained independently of virus DNA synthesis. It is noteworthy that the VGF (VV growth factor), although involved, is not essential for prolonged ERK1/2 activation. Furthermore, our findings suggest that the VV-stimulated ERK1/2 activation also seems to require actin dynamics, microtubule polymerization and tyrosine kinase phosphorylation. The VV-stimulated pathway MEK/ERK1/2/RSK2 (where MEK stands for MAPK/ERK kinase) leads to phosphorylation of the ternary complex factor Elk-1 and expression of the early growth response (egr-1) gene, which kinetically paralleled the kinase activation. The recruitment of this pathway is biologically relevant, since its disruption caused a profound effect on viral thymidine kinase gene expression, viral DNA replication and VV multiplication. This pattern of sustained kinase activation after VV infection is unique. In addition, by connecting upstream signals generated at the cytoskeleton and by tyrosine kinase, the MEK/ERK1/2/RSK2 cascade seems to play a decisive role not only at early stages of the infection, i.e. post-penetration, but is also crucial to define the fate of virus progeny.

Vaccinia virus (VV) triggers a mitogenic signal at an early stage of infection. VV-induced proto-oncogene c-fos mRNA with kinetics paralleling that stimulated by serum. The VV virokine, or vaccinia virus growth factor (VGF), was not crucial for c-fosinduction because it was observed upon infection with the virokine-minus mutant VV (VGF⁻). Furthermore, c-fos expression did not require infectious virus particles, as it occurred even with UV-inactivated VV and was equally induced by the different multiplicities of infection, i.e.1.0, 5.0, and 25.0. c-fos expression was preceded by VV-induced DNA binding activity and was mediated via the cis-acting elements serum response element (SRE), activating protein-1 (AP-1), and cAMP-response element (CRE). VV activated the protein kinases p42MAPK/ERK2 and p44MAPK/ERK1 and the transcription factor ATF1 in a time-dependent manner with kinetics that paralleled those of VV-stimulated DNA-protein complex formation. The mitogenic signal transmission pathways leading to c-fos activation upon VV infection were apparently mediated by the protein kinases MEK, ERK, and PKA. This assumption was based on the findings that: 1) c-fos transcript was down-regulated; 2) the SRE, AP-1, and CRE binding activities were significantly reduced; and 3) the activation of p42MAPK/ERK2, p44MAPK/ERK1, and ATF1 were drastically affected when the viral infections were carried out in the presence of specific protein kinase inhibitor. Moreover, the mutant VV (VGF⁻) was also able to activate ERK1/2. It is noteworthy that virus multiplication was equally affected by the same kinase inhibitors. Taken together, our data provide evidence that the early mitogenic signal triggered upon VV infection relies upon the activation of the protein kinases MEK, ERK, and PKA, which are needed for both signal transduction and virus multiplication.

Renal ischemia/reperfusion (I/R) is a complex syndrome involving several mechanisms, including renal vasoconstriction, tubular damage, and glomerular injury¹ x 1. Bird, J.E., Milhoan, K., Wilson, C.B. et al. Ischemic acute renal failure and antioxidant therapy in the rat. The relation between glomerular and tubular dysfunction. J Clin Invest. 1988; 81: 1630–1638 Crossref | PubMed | Scopus (115) | Google Scholar See all References . It is an important cause of renal dysfunction in renal transplantation and is associated with an increased rate of acute and chronic rejection² x 2. Tilney, N.L. and Guttmann, R.D. Effect of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation. 1997; 64: 945–947 https://doi.org/10.1097/00007890-199710150-00001 Crossref | PubMed | Scopus (194) | Google Scholar See all References . Although the restoration of blood flow (i.e., reperfusion) is the treatment of choice following acute ischemia of a vascular territory, reperfusion of ischemic tissues can be accompanied by significant injury to local and remote organs, such as the lung, and systemic inflammatory events that may limit the beneficial effects of blood flow restoration³ x 3. Willerson, J.T. Pharmacologic approaches to reperfusion injury. Adv Pharmacol. 1997; 39: 291–312 Crossref | PubMed | Scopus (36) | Google Scholar See all References . The mechanisms proposed to explain the reperfusion-associated injury include anoxia, release of reactive oxygen species, such as superoxide radical and hydrogen peroxide, recruitment and activation of leukocytes and subsequent release of mediators of the inflammatory process^3. x 3. Willerson, J.T. Pharmacologic approaches to reperfusion injury. Adv Pharmacol. 1997; 39: 291–312 Crossref | PubMed | Scopus (36) | Google Scholar See all References ^{, 4.} x 4. Paller, M.S., Hoidal, J.R., and Ferris, T.F. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984; 74: 1156–1164 Crossref | PubMed | Scopus (779) | Google Scholar See all References ^{, 5.} x 5. Bonventre, J.V. Mechanisms of ischemic acute renal failure. Kidney Int. 1993; 43: 1160–1178 Abstract | Full Text PDF | PubMed | Scopus (418) | Google Scholar See all References . Neutrophil and tumor necrosis factor-α (TNF-α) are among the cell types and inflammatory mediators, respectively, thought to be of major relevance in the pathophysiology of I/R injury^6. x 6. Kubes, P., Niu, X.F., Smith, C.W. et al. A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J. 1995; 9: 1103–1111 PubMed | Google Scholar See all References ^{, 7.} x 7. Gilmont, R.R., Dardano, A., Engle, J.S. et al. TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. J Surg Res. 1996; 61: 175–182 https://doi.org/10.1006/jsre.1996.0101 Abstract | Full Text PDF | PubMed | Scopus (40) | Google Scholar See all References ^{, 8.} x 8. Cornejo, C.J., Winn, R.K., and Harlan, J.M. Anti-adhesion therapy. Adv Pharmacol. 1997; 39: 99–142 Crossref | PubMed | Scopus (57) | Google Scholar See all References ^{, 9.} x 9. Souza, D.G., Cara, D.D., Cassali, G.D. et al. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischemia of the superior mesenteric artery in the rat. Br J Pharmacol. 2000; 131: 1800–1808 https://doi.org/10.1038/sj.bjp.0703756 Crossref | PubMed | Scopus (68) | Google Scholar See all References . It is believed that strategies limiting reperfusion-induced influx of neutrophils and production of TNF-α may be useful therapeutic adjuncts in the treatment of acute ischemia⁹ x 9. Souza, D.G., Cara, D.D., Cassali, G.D. et al. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischemia of the superior mesenteric artery in the rat. Br J Pharmacol. 2000; 131: 1800–1808 https://doi.org/10.1038/sj.bjp.0703756 Crossref | PubMed | Scopus (68) | Google Scholar See all References .

A new synthetic antimalarial drug, a salt derived from two antimalarial molecules, mefloquine (MQ) and artesunate (AS), here named MEFAS, has been tested for its pharmacological activity. Combinations of AS plus MQ hydrochloride are currently being used in areas with drug-resistant Plasmodium falciparum parasites; although AS clears parasitemia in shorter time periods than any other antimalarial drug, it does not cure infected patients; in addition, MQ causes side effects and is rather expensive, important problems considering that malaria affects mostly populations in poor countries. Here, we show that MEFAS is more effective than the combination of AS and MQ, tested in parallel at different mass proportions, against P. falciparum (chloroquine-resistant clone W2 and chloroquine-sensitive clone 3D7) in vitro and in mice infected with Plasmodium berghei , promoting cure of this infection. MEFAS tested against HepG2 hepatoma cells exhibited lower toxicity than the antimalarials AS and MQ alone or combined. Possible targets of MEFAS have been studied by confocal microscopy using fluorescent probes (Fluo-4 AM and BCECF-AM) in P. falciparum synchronous culture of W2-infected red blood cells. Dynamic images show that MEFAS exhibited intracellular action increasing cytoplasmic Ca ²⁺ at 1.0 ng/ml. This effect was also observed in the presence of tapsigargin, an inhibitor of SERCA, suggesting an intracellular target distinct from the endoplasmic reticulum. Trophozoites loaded with BCECF-AM, when treated with MEFAS, were still able to mobilize protons from the digestive vacuole (DV), altering the pH gradient. However, in the presence of bafilomycin A1, an inhibitor of the H ⁺ pump from acidic compartments of eukaryotic cells, MEFAS had no action on the DV. In conclusion, the endoplasmic reticulum and DV are intracellular targets for MEFAS in Plasmodium sp., suggesting two modes of action of this new salt. Our data support MEFAS as a candidate for treating human malaria.